BB Biotech AG
Investment company focused on public biotechnology firms developing novel drugs.
BION | SW
Overview
Corporate Details
- ISIN(s):
- CH0027659793 (+1 more)
- LEI:
- 391200MBZQNPFHIVKO34
- Country:
- Switzerland
- Address:
- Schwertstrasse 6, 8200 Schaffhausen
Description
BB Biotech AG is an investment company specializing in the fast-growing biotechnology market. With over 30 years of experience, it is one of the world's largest investors in this sector. The company's investment strategy focuses on a portfolio of publicly listed companies that are developing and commercializing novel drugs. These target companies are selected for their potential to create significant value for the healthcare system by addressing unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-21 01:00 |
EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals an…
|
English | 5.4 KB | ||
| 2024-03-21 01:00 |
EQS-News: Die Generalversammlung der BB Biotech AG stimmt allen Anträgen zu und…
|
German | 5.6 KB | ||
| 2024-02-21 17:40 |
BB BIOTECH AG: Prof. Dr. Mads Krogsgaard Thomsen, buy
|
English | 7.7 KB | ||
| 2024-02-16 07:00 |
BB Biotech AG publishes its 2023 annual report
|
English | 8.3 KB | ||
| 2024-02-16 01:00 |
EQS-Adhoc: BB Biotech AG publishes its 2023 annual report
|
English | 6.4 KB | ||
| 2024-02-16 01:00 |
EQS-Adhoc: BB Biotech AG veröffentlicht Geschäftsbericht 2023
|
German | 6.7 KB | ||
| 2024-02-16 00:00 |
Jahresfinanzbericht 2023
|
German | 22.1 MB | ||
| 2024-02-14 07:00 |
Investor interest returns dividend yield remains high for 2024
|
English | 12.8 KB | ||
| 2024-02-14 01:00 |
EQS-News: Investor interest returns – dividend yield remains high for 2024
|
English | 10.4 KB | ||
| 2024-02-14 01:00 |
EQS-News: Anlegerinteresse kehrt zurück – Unverändert hohe Dividendenrendite im…
|
German | 11.1 KB | ||
| 2024-01-19 07:00 |
BB Biotech AG publishes financial results for 2023 and changes to the Board of …
|
English | 7.5 KB | ||
| 2024-01-19 01:00 |
EQS-News: BB Biotech AG: End of year biotech equity market rally – M&A and end …
|
English | 22.2 KB | ||
| 2024-01-19 01:00 |
EQS-News: BB Biotech AG: Jahresendrally des Biotechsektors durch M&A-Aktivitäte…
|
German | 24.8 KB | ||
| 2024-01-19 01:00 |
EQS-Adhoc: BB Biotech AG publishes financial results for 2023 and changes to th…
|
English | 5.8 KB | ||
| 2024-01-19 01:00 |
EQS-Adhoc: BB Biotech AG publiziert Geschäftsergebnis 2023 und gibt Veränderung…
|
German | 6.2 KB |
Automate Your Workflow. Get a real-time feed of all BB Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BB Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BB Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-05 | N/A | Non-Executive member | Buy | None | 40,893.80 CHF |
| 2024-09-16 | N/A | Non-Executive member | Buy | None | 47,103.20 CHF |
| 2024-07-29 | N/A | Non-Executive member | Buy | None | 54,913.50 CHF |
| 2024-04-30 | N/A | Non-Executive member | Buy | None | 41,450.00 CHF |
| 2024-03-25 | N/A | Non-Executive member | Buy | None | 55,167.50 CHF |
| 2024-03-22 | N/A | Non-Executive member | Buy | None | 105,927.16 CHF |
Peer Companies
